SBRA - Sabra Health Care REIT, Inc.
NASDAQ
->
Real Estate
->
REIT—Healthcare Facilities
Irvine,
United States
Type: Equity
SBRA price evolution
SBRA
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $42.31 | $65.93 | $46.72 | |
| Short term investments | ||||
| Net receivables | $114.26 | $146.14 | $148.4 | $133.81 |
| Inventory | ||||
| Total current assets | $177.26 | $171.84 | $196.92 | $175.09 |
| Long term investments | ||||
| Property, plant & equipment | $4581.47 | $4566.16 | $4577.32 | $4617.26 |
| Goodwill & intangible assets | $27.72 | $28.3 | $30.9 | |
| Total noncurrent assets | ||||
| Total investments | $568.79 | $554.49 | $557.47 | |
| Total assets | $5366.13 | $5351.12 | $5374.44 | $5386.15 |
| Current liabilities | ||||
| Accounts payable | $91.11 | $112.83 | $112.76 | $136.98 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $122.81 | $112.83 | $112.76 | $136.98 |
| Long term debt | $2470.21 | $2446.62 | $2463.39 | $2414.1 |
| Total noncurrent liabilities | ||||
| Total debt | $2446.62 | $2463.39 | $2414.1 | |
| Total liabilities | $2621.28 | $2589.14 | $2607.26 | $2583.62 |
| Shareholders' equity | ||||
| Retained earnings | -$1849.17 | -$1808.16 | -$1762 | -$1718.28 |
| Other shareholder equity | $16.94 | $31.14 | $31.2 | $23.75 |
| Total shareholder equity | $2761.97 | $2767.17 | $2802.53 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $46.72 | $53.93 | $115.89 | $65.52 |
| Short term investments | ||||
| Net receivables | $133.81 | $147.91 | $138.11 | $160.65 |
| Inventory | ||||
| Total current assets | $175.09 | $197.22 | $250.1 | $219.7 |
| Long term investments | ||||
| Property, plant & equipment | $4617.26 | $4959.34 | $5162.88 | $5285.04 |
| Goodwill & intangible assets | $30.9 | $40.13 | $54.06 | $82.8 |
| Total noncurrent assets | ||||
| Total investments | $557.47 | $546.36 | $495.77 | $391.6 |
| Total assets | $5386.15 | $5747.67 | $5966.71 | $5985.6 |
| Current liabilities | ||||
| Accounts payable | $136.98 | $124.06 | $142.99 | $146.28 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $136.98 | $142.26 | $142.99 | $146.3 |
| Long term debt | $2414.1 | $2506.77 | $2394.47 | $2372.4 |
| Total noncurrent liabilities | ||||
| Total debt | $2414.1 | $2506.77 | $2394.47 | $2372.37 |
| Total liabilities | $2583.62 | $2691.28 | $2587.18 | $2576.38 |
| Shareholders' equity | ||||
| Retained earnings | -$1718.28 | -$1451.94 | -$1095.2 | -$716.2 |
| Other shareholder equity | $23.75 | $19.06 | -$10.02 | -$39.91 |
| Total shareholder equity | $2802.53 | $3056.39 | $3379.53 | $3409.23 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $176.14 | $166.75 | $163.4 | |
| Cost of revenue | ||||
| Gross Profit | $176.14 | $166.75 | $163.4 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $12.74 | $11.89 | $16.68 | |
| Total operating expenses | $124.51 | $111.93 | $116.34 | |
| Operating income | $51.63 | $54.81 | $47.05 | |
| Income from continuing operations | ||||
| EBIT | $53.73 | $55.12 | $45.59 | |
| Income tax expense | $0.44 | $0.45 | $0.49 | |
| Interest expense | $29.31 | $28.41 | $27.94 | |
| Net income | ||||
| Net income | $23.98 | $26.25 | $17.16 | |
| Income (for common shares) | $23.98 | $26.25 | $17.16 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $647.51 | $624.81 | $569.54 | $598.57 |
| Cost of revenue | ||||
| Gross Profit | $647.51 | $624.81 | $569.54 | $598.57 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $47.47 | $39.57 | $34.67 | $32.76 |
| Total operating expenses | $440.33 | $484.15 | $368.3 | $346.9 |
| Operating income | $207.19 | $140.66 | $201.25 | $251.67 |
| Income from continuing operations | ||||
| EBIT | $128.72 | $29.11 | -$12.78 | $239.55 |
| Income tax expense | $2 | $1.24 | $1.84 | $0.71 |
| Interest expense | $112.96 | $105.47 | $98.63 | $100.42 |
| Net income | ||||
| Net income | $13.76 | -$77.61 | -$113.26 | $138.42 |
| Income (for common shares) | $13.76 | -$77.61 | -$113.26 | $138.42 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $23.98 | $26.25 | $17.16 | |
| Operating activities | ||||
| Depreciation | $41.68 | $42.91 | $42.88 | |
| Business acquisitions & disposals | -$0.16 | -$0.19 | -$0.44 | |
| Stock-based compensation | $1.34 | $2.52 | $2.45 | |
| Total cash flows from operations | $80.13 | $52.8 | $78.74 | |
| Investing activities | ||||
| Capital expenditures | -$42.4 | -$12.94 | -$60.56 | |
| Investments | -$14.76 | -$0.1 | -$0.58 | |
| Total cash flows from investing | -$127.56 | -$57.31 | -$13.22 | -$61.78 |
| Financing activities | ||||
| Dividends paid | -$209.17 | -$69.45 | -$69.44 | -$69.37 |
| Sale and purchase of stock | $39.01 | -$2.61 | -$0.49 | |
| Net borrowings | -$15.97 | $51.82 | $60.49 | |
| Total cash flows from financing | -$80.6 | -$46.41 | -$20.23 | -$9.36 |
| Effect of exchange rate | -$0.16 | -$0.03 | -$0.13 | $0.27 |
| Change in cash and equivalents | $22.26 | -$23.59 | $19.34 | $7.59 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $13.76 | -$77.61 | -$113.26 | $138.42 |
| Operating activities | ||||
| Depreciation | $183.09 | $187.78 | $178.99 | $176.74 |
| Business acquisitions & disposals | -$5.24 | -$142.91 | $1.3 | |
| Stock-based compensation | $7.92 | $7.45 | $7.91 | $7.91 |
| Total cash flows from operations | $300.57 | $315.73 | $356.39 | $354.85 |
| Investing activities | ||||
| Capital expenditures | $84.24 | -$51.37 | -$41.38 | -$140.3 |
| Investments | $17.78 | -$21.96 | -$294.82 | -$14.21 |
| Total cash flows from investing | $103.13 | -$216.25 | -$336.2 | -$136.45 |
| Financing activities | ||||
| Dividends paid | -$277.45 | -$277.16 | -$262.92 | -$278.3 |
| Sale and purchase of stock | -$2.68 | -$4.81 | $308.71 | $80.09 |
| Net borrowings | -$112.27 | $122.76 | -$15.65 | -$3.9 |
| Total cash flows from financing | -$410.3 | -$161.71 | $30.14 | -$202.11 |
| Effect of exchange rate | -$0.61 | $0.27 | $0.03 | $0.09 |
| Change in cash and equivalents | -$6.6 | -$62.22 | $50.33 | $16.29 |
News
Fundamentals
| Market cap | $4.20B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 236.59M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.92 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.44 |
| Quick ratio | N/A |